
Jia Liu and Herbert Loong
May 1, 2025, 09:49
Jia (Jenny) Liu Congratulates Herbert Loong on AACR25 and Nature Medicine Publication
Jia (Jenny) Liu, Translational Researcher at The Kinghorn Cancer Centre, shared a post on X:
“Congratulations Herbert Loong and team on the AACR25 oral and simultaneous publication Nature Medicine of D3S-001 next gen G12C inhibitor in KRASm -phase 1 trial!
Great excuse to celebrate with whilst in Chicago!”
Herbert Loong, Chair-Elect of the International Affairs Committee and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO), reshared the post on X, adding:
“Thanks Jia (Jenny) Liu! Amazing food and conversations indeed!
Looking forward to welcoming you to Hong Kong for ESMO – Eur. Oncology ESMOTATAsia25 in July when we can continue our culinary excursions.”
More posts featuring Herbert Loong.
AACR25
American Society of Clinical Oncology
ASCO
cancer
Chicago
D3S-001
ESMO - Eur. Oncology
ESMOTATAsia25
fight against cancer
G12C inhibitor
Global fight against cancer
Herbert Loong
Hong Kong
Jia (Jenny) Liu
KRASm -phase 1 trial
Nature Medicine
OncoDaily
Oncology
The Kinghorn Cancer Centre
Translational Researcher
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 1, 2025, 15:20
May 1, 2025, 14:51
May 1, 2025, 14:30
May 1, 2025, 14:00
May 1, 2025, 13:26
May 1, 2025, 13:03